SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $102K invested in Salarius Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$957
2
+$127

Top Sellers

1
-$19.5K
2
-$15.7K
3
-$8.45K
4
AC
Armistice Capital
New York
-$2.09K
5
UBS Group
UBS Group
Switzerland
-$51
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$44.4K
2
$16.4K
3
$15K
4
$13.1K
5
$7.7K
6
$4.46K
7
$733
8
$32
9
$16
10
$10
11
$8
12
$8
13
$4
14
–
15
–
16
–